Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer ... and transarterial chemoembolization (TACE), are ...

Liver cancer could hit you sooner than you think. In an interview with HT Lifestyle, Dr Amar Mukund, Professor and Head of ...

Liver cancer, particularly Hepatocellular Carcinoma (HCC), is fast emerging as one of India’s most pressing health challenges ...

Japanese researchers sought to build upon prior studies demonstrating the feasibility of liver resection in geriatric hepatocellular carcinoma patients, particularly in those undergoing major ...

David M. Dudzinski: A 59-year-old man with a history of obesity, dyslipidemia, and hypertension was evaluated in the oncology clinic of this hospital because of hepatocellular carcinoma.

Transarterial chemoembolization (TACE) is currently the most common approach for the management of hepatocellular carcinoma (HCC) without curative options. TACE consists of the injection of ...